The Pharmaceutical Service Provider sector is seeing substantial expansion, fueled by increasing biopharmaceutical demand and a move towards contracting of manufacturing processes. Key outlook include a greater emphasis on advanced therapies such as genetic therapies, customized therapeutics, and